You are here

Emedonline: Telemedicine Medication Management System

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AG022271-01
Agency Tracking Number: AG022271
Amount: $99,993.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Solicitation Year: N/A
Award Year: 2003
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 (815) 356-1767
Business Contact
Phone: (815) 356-1767
Research Institution

DESCRIPTION (provided by investigator): Medication non-compliance is estimated to cost the US healthcare system an estimated $76.6 billion a year. Approximately 10% of hospital admissions are related to medication issues, costing up to $50 billion annually. Understanding the causes of noncompliance and identifying methods to help patients follow their regimens may improve health outcomes and reduce related costs. We propose to determine whether a medication management system improves compliance among elderly patients being treated for hypertension. The medication management system, called Emedonline, uses standard cellular phone technology to call patients at programmed intervals, gives voice, text, and graphic instructions for taking prescribed medications, and dispenses the medications. It focuses specifically on modifying social interaction factors and providing a tool to enhance the administration process. We have identified three key objectives toward achieving Phase I and Phase II goals: 1. Develop Emedonline to facilitate prescribing medication regimens for healthcare providers, and facilitate medication compliance for patients. 2. Assess the acceptability of the service among healthcare providers, pharmacists, and patients. 3. Evaluate effects on medication compliance, perceived social support, and feelings of control over health destiny. During Phase I, we will examine requirements through focus groups with a sample of healthcare providers, pharmacists, and patients; develop a prototype of the Emedonline system; conduct a concept test with the sample; and create detailed specifications for Phase II development.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government